scholarly journals Enabling Reductions in Maintenance ICS/LABA Therapy Using as Needed Anti-Inflammatory Reliever for Patients with Severe Eosinophilic Asthma Controlled with Benralizumab: SHAMAL Phase IV Clinical Study

2020 ◽  
Author(s):  
D.J. Jackson ◽  
B.D. Kent ◽  
M. Humbert ◽  
L.G. Heaney ◽  
S. Korn ◽  
...  
Keyword(s):  
Clinical Study ◽  
Eosinophilic Asthma ◽  
Severe Eosinophilic Asthma ◽  
Anti Inflammatory ◽  
Phase Iv

scholarly journals Regulatory T cell monitoring in severe eosinophilic asthma patients treated with mepolizumab

2021 ◽  
Author(s):  
Laura Bergantini ◽  
Miriana d’Alessandro ◽  
Paolo Cameli ◽  
Clara Bono ◽  
Marco Perruzza ◽  
...  
Keyword(s):  
T Cell ◽  
Regulatory T Cell ◽  
Eosinophilic Asthma ◽  
Severe Eosinophilic Asthma ◽  
Asthma Patients ◽  
Cell Monitoring

Results in clinical practice in the treatment of severe eosinophilic asthma with mepolizumab: a real-life study

2021 ◽  
pp. 1-7
Author(s):  
Ana Isabel Enríquez-Rodríguez ◽  
Tamara Hermida Valverde ◽  
Pedro Romero Álvarez ◽  
Francisco Julián López-González ◽  
Jose Antonio Gullón Blanco ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Real Life ◽  
Eosinophilic Asthma ◽  
Life Study ◽  
Severe Eosinophilic Asthma ◽  
Real Life Study

scholarly journals Basophil activation and serum IL‐5 levels as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti‐IL‐5 drugs

Allergy ◽  
2020 ◽  
Author(s):  
Cristiano Caruso ◽  
Stefania Colantuono ◽  
Barbara Tolusso ◽  
Clara Di Mario ◽  
Antonella Pentassuglia ◽  
...  
Keyword(s):  
Basophil Activation ◽  
Eosinophilic Asthma ◽  
Severe Eosinophilic Asthma ◽  
Asthma Patients
Sign in / Sign up

Export Citation Format

Share Document